•  
  •  
  •  
  •  

2026-02-07 09:03:46

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Fusion Finance Q3 FY26: Disbursements Surge 23% QoQ to ₹1,594 Cr, PAT Swings to ₹14 Cr Profit
  • Nifty Recovers 200 Points to End the Session Near Day high
  • Gateway Distriparks Q3 FY26: Revenue Soars 39% to ₹566 Cr, PAT Up 4% - Declares ₹2 Special Dividend on Debt-Free Milestone
  • Mamaearth Onboards Sreeleela as Hair Care Category Brand Ambassador; Unveils Valentine's Day Film for Rosemary Anti-Hair Fall Shampoo
  • Wanbury Limited Q3 FY26: PAT Explodes 1,194% YoY to ₹15.8 Cr, Revenue Up 22%

Keywords Selected:  ZeroObservation

Stock Report

  • Granules India's Packaging Facility in US Completes FDA inspection with Zero Observations
  • Lupin Bioresearch Center receives Zero Observations from U.S. FDA after Successful Inspection and Assessment
  • USFDA successfully completes inspection at Indoco's API manufacturing facility at Patalganga with zero observations
  • Emcure Pharmaceuticals Ltd successfully completes USFDA PAI of Oncology facility
  • Wanbury Limited successfully completes ANVISA audit at its Tanuku plant
  • Alembic Pharmaceuticals Ltd's Oncology facility successfully completes USFDA inspection
  • U.S. FDA inspection at Glenmark Pharmaceuticals Ltd's Facility at Chhatrapati Sambhaji Nagar, India
  • ANVISA - Brazil completes inspection at Caplin Steriles' facility at Gummidipoondi
  • Wanbury's Patalganga Manufacturing Facility clears US FDA Inspection with Zero Observations
  • USFDA completes inspection at Auro Peptides Ltd's facility with zero observations
  • NATCO Pharma announces successful completion of USFDA inspection
  • Granules India successfully completes Two US FDA Audits in a span of 2 weeks
  • USFDA completes inspection at Dr Reddy's Laboratories Ltd's Bollaram API unit
  • USFDA inspection at Zydus' injectables manufacturing facility at Zydus Biotech Park, concludes with Nil observations
  • Alembic Pharmaceuticals Ltd announces Successful completion of USFDA inspection at Derma Facility at Karakhadi
  • US FDA Inspection at JNPC Facility, Visakhapatnam of Gland Pharma Ltd
  • Piramal Pharma Ltd gets zero observations from USFDA for Riverview, Michigan facility
  • SMS Lifesciences India successfully completes USFDA inspection at its API facility
  • USFDA inspection at Torrent's manufacturing facility at Levittown, Pennsylvania, USA

Latest Post

  • Fusion Finance Q3 FY26: Disbursements Surge 23% QoQ to ₹1,594 Cr, PAT Swings to ₹14 Cr Profit
  • Nifty Recovers 200 Points to End the Session Near Day high
  • Gateway Distriparks Q3 FY26: Revenue Soars 39% to ₹566 Cr, PAT Up 4% - Declares ₹2 Special Dividend on Debt-Free Milestone
  • Mamaearth Onboards Sreeleela as Hair Care Category Brand Ambassador; Unveils Valentine's Day Film for Rosemary Anti-Hair Fall Shampoo
  • Wanbury Limited Q3 FY26: PAT Explodes 1,194% YoY to ₹15.8 Cr, Revenue Up 22%


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025